Oscar Health (NYSE:OSCR) CEO Mark Bertolini Sells 615,142 Shares of Stock

Oscar Health, Inc. (NYSE:OSCR) CEO Mark Bertolini sold 615,142 shares of the company’s stock in a transaction dated Thursday, June 25th. The stock was sold at an average price of $28.61, for a total transaction of $17,599,212.62. Following the completion of the transaction, the chief executive officer owned 9,581,734 shares of the company’s stock, valued at approximately $274,133,409.74. This trade represents a 6.03% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Oscar Health Stock Performance

OSCR opened at $29.37 on Tuesday. The business’s 50 day moving average is $23.30 and its 200-day moving average is $17.45. The stock has a market cap of $8.85 billion, a PE ratio of -49.78, a price-to-earnings-growth ratio of 2.08 and a beta of 2.37. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a twelve month low of $10.69 and a twelve month high of $30.66.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $2.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.11 by $0.96. Oscar Health had a negative return on equity of 3.26% and a negative net margin of 0.30%.The business had revenue of $4.65 billion during the quarter, compared to the consensus estimate of $4.90 billion. During the same period in the previous year, the firm posted $0.92 earnings per share. The business’s revenue was up 52.6% on a year-over-year basis. On average, analysts predict that Oscar Health, Inc. will post 0.47 earnings per share for the current year.

Analysts Set New Price Targets

OSCR has been the subject of several recent analyst reports. Zacks Research cut Oscar Health from a “strong-buy” rating to a “hold” rating in a research note on Friday, June 5th. Wells Fargo & Company set a $20.00 price objective on shares of Oscar Health and gave the company an “equal weight” rating in a research note on Thursday, June 4th. Wall Street Zen raised shares of Oscar Health from a “buy” rating to a “strong-buy” rating in a report on Sunday, June 14th. Weiss Ratings lowered shares of Oscar Health from a “sell (d+)” rating to a “sell (d)” rating in a research report on Wednesday, June 24th. Finally, Robert W. Baird raised their target price on shares of Oscar Health from $15.00 to $19.00 and gave the company a “neutral” rating in a research note on Thursday, May 7th. Three research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $20.78.

Hedge Funds Weigh In On Oscar Health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in OSCR. Jones Financial Companies Lllp increased its position in shares of Oscar Health by 7,473.3% during the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock valued at $30,000 after purchasing an additional 2,242 shares during the period. Strs Ohio acquired a new stake in shares of Oscar Health in the first quarter valued at $30,000. Fifth Third Bancorp boosted its stake in Oscar Health by 148.7% during the fourth quarter. Fifth Third Bancorp now owns 2,363 shares of the company’s stock valued at $34,000 after buying an additional 1,413 shares in the last quarter. Quarry LP boosted its stake in Oscar Health by 439.8% during the third quarter. Quarry LP now owns 1,803 shares of the company’s stock valued at $34,000 after buying an additional 1,469 shares in the last quarter. Finally, Harel Insurance Investments & Financial Services Ltd. acquired a new position in Oscar Health during the first quarter worth about $49,000. 75.70% of the stock is owned by institutional investors.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.